Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention

Copyright © 2022. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 245(2022) vom: 20. Dez., Seite 109095
Auteur principal: O'Shea, Anne E (Auteur)
Autres auteurs: Valdera, Franklin A, Ensley, Daniel, Smolinsky, Todd R, Cindass, Jessica L, Kemp Bohan, Phillip M, Hickerson, Annelies T, Carpenter, Elizabeth L, McCarthy, Patrick M, Adams, Alexandra M, Vreeland, Timothy J, Clifton, Guy T, Peoples, George E
Format: Article en ligne
Langue:English
Publié: 2022
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Review Chemoprevention Rapamycin mTOR Immunosuppressive Agents Sirolimus W36ZG6FT64 TOR Serine-Threonine Kinases EC 2.7.11.1